News and Announcements
PharmAust Ltd – Human Cancer Trial Advancing to Second Patient
- Published October 23, 2014 12:56PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
ASX Release – Tuesday 21 October 2014
PharmAust Limited (ASX; PAA & PAAO) is pleased to report that it is now advancing to the treatment of the second patient in its “First in Man” trial with PPL-1. Following the approval of the study by the Royal Adelaide Hospital research Ethics Committee in April 2014, the Company commenced recruitment and treatment of the first patient with its anti-cancer drug PPL-1. Unfortunately, the first patient passed away due to reasons unrelated to the study drug and this has understandably resulted in a standard process of investigations resulting in delays in the treatment of the second patient.
CMAX with the assistance and guidance of the Principal Investigator, Professor Michael Brown, will resubmit the ethics application to the Royal Adelaide Hospital Ethic Committee to seek approval for advancing the clinical trial.
To view the full ASX Release please, click here.
Company Updates
Built on discipline, not complexity: inside an ASX equities income strategy
Haydn Froggatt and Zac Brabin have decades of derivatives experience between them and access to almost any strategy in the market. They use two of the simplest structures available, and wrote 202 positions with them last year. Published by Fairway Capital Management. Based on an interview with co-founders Haydn Froggatt and Zac Brabin. Two traders, […]
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
Backed By Leading Investment Groups and Family Offices
